Karaman, O. (2025) “CD19 Chimeric Antigen Receptor (CAR) modified cytokine killer cells compared to classical CD19 CAR-T: advantages and disadvantages”, South East European Journal of Immunology, 8(CITIM), p. 062. doi: 10.3889/seejim.2025.6123.